Search Orphan Drug Designations and Approvals
-
| Generic Name: | Degrader of Lysine-specific histone demethylase 1A and REST Corepressor 1 |
|---|---|
| Date Designated: | 01/25/2023 |
| Orphan Designation: | Treatment of Glioblastoma |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Beactica Therapeutics AB Virdings allé 2 Uppsala 754 50 Sweden The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







